We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.45B
AUM Growth
+$284M
Cap. Flow
-$20.5M
Cap. Flow %
-0.46%
Top 10 Hldgs %
34.33%
Holding
1,079
New
59
Increased
179
Reduced
284
Closed
85

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$41.1M
2
ADBE icon
Adobe
ADBE
+$23M
3
NSC icon
Norfolk Southern
NSC
+$13.8M
4
META icon
Meta Platforms (Facebook)
META
+$10.6M
5
OTIS icon
Otis Worldwide
OTIS
+$6.73M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
CVS icon
CVS Health
CVS
+$24.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$16.5M
4
UNH icon
UnitedHealth
UNH
+$14.5M
5
NVDA icon
NVIDIA
NVDA
+$6.26M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Healthcare 16.06%
3 Financials 12.32%
4 Consumer Discretionary 10.19%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CC icon
876
Chemours
CC
$2.59B
$3.69K ﹤0.01%
100
– –
NVTA
877
DELISTED
Invitae Corporation
NVTA
$3.66K ﹤0.01%
3,240
– –
ACCO icon
878
Acco Brands
ACCO
$369M
$3.65K ﹤0.01%
700
– –
HIMX
879
Himax Technologies
HIMX
$2.2B
$3.65K ﹤0.01%
540
– –
TYG
880
Tortoise Energy Infrastructure Corp
TYG
$1.14B
$3.63K ﹤0.01%
125
– –
CDNS icon
881
Cadence Design Systems
CDNS
$90B
$3.52K ﹤0.01%
15
– –
IVZ icon
882
Invesco
IVZ
$13.3B
$3.38K ﹤0.01%
201
– –
EPAM icon
883
EPAM Systems
EPAM
$4.69B
$3.37K ﹤0.01%
15
+10
+200% +$2.52K
TDOC icon
884
Teladoc Health
TDOC
$1.58B
$3.34K ﹤0.01%
132
– –
BLUE
885
DELISTED
bluebird bio
BLUE
$3.29K ﹤0.01%
50
– –
URA icon
886
Global X Uranium ETF
URA
$5.52B
$3.15K ﹤0.01%
+145
New +$2.97K
VSS icon
887
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$3.09K ﹤0.01%
+28
New +$3.09K
WAB icon
888
Wabtec
WAB
$51.1B
$3.07K ﹤0.01%
28
+2
+8% +$199
STEM icon
889
Stem
STEM
$49.2M
$2.86K ﹤0.01%
25
– –
HBI
890
DELISTED
Hanesbrands
HBI
$2.77K ﹤0.01%
610
– –
IQ icon
891
iQIYI
IQ
$1.18B
$2.74K ﹤0.01%
513
– –
MTCH icon
892
Match Group
MTCH
$8.84B
$2.72K ﹤0.01%
65
– –
CELH icon
893
Celsius Holdings
CELH
$6.93B
$2.69K ﹤0.01%
54
– –
FABC
894
Fabric.AI Inc
FABC
$16.8M
$2.67K ﹤0.01%
30
– –
NTLA icon
895
Intellia Therapeutics
NTLA
$1.5B
$2.65K ﹤0.01%
65
– –
FITB
896
Fifth Third Bancorp
FITB
$52B
$2.65K ﹤0.01%
+101
New +$2.6K
ASHR icon
897
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.35B
$2.62K ﹤0.01%
+98
New +$2.77K
IEV icon
898
iShares Europe ETF
IEV
$1.63B
$2.53K ﹤0.01%
50
– –
PEGA icon
899
Pegasystems
PEGA
$4.41B
$2.46K ﹤0.01%
100
– –
ZIMV
900
DELISTED
ZimVie
ZIMV
$2.45K ﹤0.01%
218
+16
+8% +$155
34 35
36
37 38

Similar funds

AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return

HM Payson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, HM Payson & Co held 1,079 positions worth $4.45B, up 6.8% from $4.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

HM Payson & Co's Q2 2023 filing shows 59 new, 179 increased, 284 reduced and 85 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M. The largest sale was Pfizer, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2023 buy was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M.
  • HM Payson & Co added most to Marathon Petroleum in Q2 2023, an estimated $41.1M increase.
  • HM Payson & Co's biggest Q2 2023 reduction was Pfizer, cutting an estimated $30M.
  • HM Payson & Co fully exited Vanguard Short-Term Bond ETF in Q2 2023, selling an estimated $3.44M.
  • HM Payson & Co's ten largest holdings make up 34% of its $4.45B portfolio in Q2 2023.
  • HM Payson & Co opened 59 new positions and closed 85 in Q2 2023.
  • HM Payson & Co's portfolio value rose 6.8% quarter-over-quarter to $4.45B.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.